Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
about
3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival.Hepatic imaging following intra-arterial embolotherapy.Schistosomiasis mansoni incidence data in Rwanda can improve prevalence assessments, by providing high-resolution hotspot and risk factors identification.The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma.Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma.
P2860
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
@ast
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
@en
type
label
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
@ast
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
@en
prefLabel
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
@ast
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
@en
P2093
P2860
P1433
P1476
Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
@en
P2093
Jean-François Geschwind
Julius Chapiro
Rafael Duran
Rongxin Chen
Zhijun Wang
P2860
P304
P356
10.1016/J.ACRA.2015.03.001
P577
2015-04-08T00:00:00Z